FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.
about
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
FOXP1 expression is a prognost ...... th rituximab and chemotherapy.
@en
FOXP1 expression is a prognost ...... th rituximab and chemotherapy.
@nl
type
label
FOXP1 expression is a prognost ...... th rituximab and chemotherapy.
@en
FOXP1 expression is a prognost ...... th rituximab and chemotherapy.
@nl
prefLabel
FOXP1 expression is a prognost ...... th rituximab and chemotherapy.
@en
FOXP1 expression is a prognost ...... th rituximab and chemotherapy.
@nl
P2093
P2860
P50
P1433
P1476
FOXP1 expression is a prognost ...... ith rituximab and chemotherapy
@en
P2093
Andreas Rosenwald
Heike Horn
Laurie H Sehn
Michael Boesl
Vindi Jurinovic
Wolfgang Hiddemann
Wolfram Klapper
P2860
P304
P356
10.1182/BLOOD-2017-08-799080
P407
P50
P577
2017-11-09T00:00:00Z